On Thursday 31st October 2024, investors and market participants can expect the release of Kymera Therapeutics (NASDAQ: KYMR) third quarter financial results. This crucial announcement will be made before market open.
It appears that the enterprise is on the verge of revealing their estimated $0.84 loss per share for the quarter, as well as their total revenue of $10.36 million for this specific period, according to financial experts on Wall Street.
Wall Street analysts have offered their forecasts for the company's yearly performance, predicting a total revenue of $56.62 million. Additionally, they are expecting the company to report loss of $2.95 per share for the fiscal year 2024.
In the corresponding quarter of the previous year, the company's earnings report unveiled a per-share loss of $0.9. Notably, the company's total revenue reached an impressive $4.73 million during that specific period.
[stock_market_widget type=”chart” template=”line2″ assets=KYMR range=”1y” interval=”1wk” price_field=”close” heading=”{symbol}” line_width=”2″ gradient_direction=”bottom” gradient_size=”1″ line_color=”#1b6dc1″ area_background_color=”#1b6dc1″ area_background_color2=”#ffffff” axes_color=”#000000″ tooltip_text_color=”#262626″ tooltip_background_color=”#ffffff” range_selector=”false” volume_enabled=”false” axes_enabled=”true” tooltip_enabled=”false” events_enabled=”false” smoothing_enabled=”true” zoom_enabled=”false” save_image_enabled=”false” api=”yahoo-finance”]
KYMR will host a conference call with investment community on 31st October 2024 at 08:30 AM eastern time to discuss the financial results.
Kymera Therapeutics (KYMR) shares traded as low as $47.75 and as high as $49.15 on a day volume of 356.80 thousand shares, closed Tuesday's regular trading session at $48.49, downfall of 1.2 percent.
